PT661051E - Medicamento para o tratamento da hipertensao - Google Patents

Medicamento para o tratamento da hipertensao

Info

Publication number
PT661051E
PT661051E PT94115833T PT94115833T PT661051E PT 661051 E PT661051 E PT 661051E PT 94115833 T PT94115833 T PT 94115833T PT 94115833 T PT94115833 T PT 94115833T PT 661051 E PT661051 E PT 661051E
Authority
PT
Portugal
Prior art keywords
product
platelets
hypertension
treatment
medicinal product
Prior art date
Application number
PT94115833T
Other languages
English (en)
Inventor
Peter Dr Koeltringer
Original Assignee
Viatris Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Viatris Gmbh filed Critical Viatris Gmbh
Publication of PT661051E publication Critical patent/PT661051E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
PT94115833T 1993-10-11 1994-10-07 Medicamento para o tratamento da hipertensao PT661051E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT204593 1993-10-11
AT209493 1993-10-18

Publications (1)

Publication Number Publication Date
PT661051E true PT661051E (pt) 2006-05-31

Family

ID=25597506

Family Applications (1)

Application Number Title Priority Date Filing Date
PT94115833T PT661051E (pt) 1993-10-11 1994-10-07 Medicamento para o tratamento da hipertensao

Country Status (9)

Country Link
US (1) US5532269A (pt)
EP (1) EP0661051B1 (pt)
JP (2) JP3370795B2 (pt)
AT (1) ATE315391T1 (pt)
CA (1) CA2133861C (pt)
DE (1) DE59410426D1 (pt)
DK (1) DK0661051T3 (pt)
ES (1) ES2256838T3 (pt)
PT (1) PT661051E (pt)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4439477C2 (de) * 1994-11-08 1999-10-21 Asta Medica Ag Verwendung von R,S-(+/-)-alpha-Liponsäure, R-(+)-alpha-Liponäure, S-(-)-alpha-Liponsäure in reduzierter oder oxidierter Form oder der Metabolite sowie deren Salze, Ester, Amide zur Behandlung der diabetischen Mikroangiopathie
US5962030A (en) 1997-03-07 1999-10-05 Akesis Pharmaceuticals, Inc. Dietary supplement and method of treatment for diabetic control
US5990153A (en) * 1997-05-05 1999-11-23 Wood; John G. Ultrasonicated α-lipoic acid solutions for attenuating microvascular injury
GB9715444D0 (en) 1997-07-22 1997-09-24 Scotia Holdings Plc Therapeutic and dietary compositions
US6090842A (en) * 1998-03-10 2000-07-18 The Regents Of The University Of California Lipoic acid analogs
US20040259895A1 (en) * 1998-05-28 2004-12-23 Medical Research Institute Oral formulation of lipid soluble thiamine and lipoic acid
US6197340B1 (en) 1998-05-28 2001-03-06 Medical Research Institute Controlled release lipoic acid
US6191162B1 (en) 1998-05-28 2001-02-20 Medical Research Institute Method of reducing serum glucose levels
US20050085498A1 (en) * 1998-05-28 2005-04-21 Byrd Edward A. Oral formulation of lipid soluble thiamine, lipoic acid, creatine derivative, and L-arginine alpha-ketoglutarate
US6905707B2 (en) * 1998-05-28 2005-06-14 Medical Research Institute Controlled release arginine alpha ketoglutarate
EP1113804A2 (en) * 1998-09-17 2001-07-11 Akesis Pharmaceuticals, Inc. Combinations of chromium or vanadium with antidiabetics for glucose metabolism disorders
US6376549B1 (en) 1998-09-17 2002-04-23 Akesis Pharmaceuticals, Inc. Metforimin-containing compositions for the treatment of diabetes
US6573299B1 (en) 1999-09-20 2003-06-03 Advanced Medical Instruments Method and compositions for treatment of the aging eye
DE10027968A1 (de) * 2000-06-08 2001-12-13 Asta Medica Ag Mittel zur Therapie von Demenzen
US7030154B2 (en) * 2002-06-07 2006-04-18 Juvenon, Inc. Stability of lipoic acid
US6787163B2 (en) * 2003-01-21 2004-09-07 Dennis H. Harris Therapeutic treatment for blood sugar regulation
US7282225B1 (en) 2006-09-27 2007-10-16 Occular Technologies, Inc. Composition and methods for improving retinal health
US20090054513A1 (en) * 2007-08-22 2009-02-26 Response Scientific, Inc. Method of managing blood glucose levels, insulin levels and/or insulin receptor functionality in individuals with diabetes, polycystic ovarian syndrome and/or alzheimer's disease
US7943163B2 (en) 2007-08-22 2011-05-17 Response Scientific, Inc. Medical food or nutritional supplement, method of manufacturing same, and method of managing diabetes
JP6205616B2 (ja) * 2011-04-28 2017-10-04 ビーエイチエヌ株式会社 美肌促進剤及びその利用
US20140065076A1 (en) * 2012-08-30 2014-03-06 Otsuka Pharmaceutical Co. Ltd. Container with concentrated substance and method of using the same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1213141B (it) * 1984-02-17 1989-12-14 Dobrivoje Tomic Composizioni farmaceutiche per il trattamento del diabete e di malattie e disfunzioni epatiche.
DE3883374T2 (de) * 1987-10-28 1993-12-09 Pro Neuron Inc Acylatiertes uridin und cytidin und deren verwendungen.
DE58902094D1 (de) * 1988-01-28 1992-10-01 Koeltringer Peter Kombinationspraeparat zur behandlung von nervenzell-und nervenfasererkrankungen und verletzungen.
DE4002706A1 (de) * 1989-02-09 1990-08-16 Asta Pharma Ag Arzneimittel enthaltend als wirkstoff dihydroliponsaeure
EP0382066A3 (de) * 1989-02-09 1992-01-08 ASTA Medica Aktiengesellschaft Verwendung von Dihydroliponsäure als Analgetikum, Antiphlogistikum und/oder Zytoprotektivum

Also Published As

Publication number Publication date
JP2002145772A (ja) 2002-05-22
ATE315391T1 (de) 2006-02-15
EP0661051A3 (de) 1995-10-18
DK0661051T3 (da) 2006-05-22
DE59410426D1 (de) 2006-04-06
EP0661051A2 (de) 1995-07-05
EP0661051B1 (de) 2006-01-11
JP3370795B2 (ja) 2003-01-27
ES2256838T3 (es) 2006-07-16
CA2133861C (en) 2004-03-30
CA2133861A1 (en) 1995-04-12
US5532269A (en) 1996-07-02
JPH07206675A (ja) 1995-08-08

Similar Documents

Publication Publication Date Title
PT661051E (pt) Medicamento para o tratamento da hipertensao
ES2035821T3 (es) Sistema de administracion enterica dirigida.
KR930702022A (ko) 인슐린의 경구 투여에 의한 타잎 1 당뇨병의 치료 또는 예방법
KR950016783A (ko) 조절 방출용 약학 조성물
SE8402550L (sv) N-substituerade deridvat av moranolin
HUP0100186A2 (hu) Laktám típusú metalloproteináz-gátló vegyületek és az ilyen vegyületeket tartalmazó gyógyászati készítmények
ES2137948T3 (es) Sistema avanzado de administracion de medicamentos y metodo de tratamiento de trastornos psiquiatricos, neurologicos y otros con carbamacepina.
KR890011590A (ko) 안지오스타틴
FI961438A (fi) beta-amyloidiproteiinituotannon estäjiä
KR950007868A (ko) 항궤양제 및 헬리코박터·피롤리의 정착저해제
GR3002605T3 (en) Pharmaceutical compositions containing a derivative of 3-hydroxy-butanoic acid chosen among oligomers of this acid and among esters of this acid or of these oligomers with 1,3-butane-diol
JPH09278663A (ja) カイガンショウからの抽出物（ＰｙｃｎｏｇｅｎｏｌＴＭ） の経口投与によるヒト血小板の反応性の調節方法
DE69224069D1 (de) Pharmazeutisches kombinationspräparat, das ein uricosurisches mittel und einen excitatorischen aminosäure-antagonisten enthält
ATE83651T1 (de) Acetylcystein enthaltende mundloesliche arzneimittel.
ES2173858T3 (es) Analogos de huperzina a.
IL85228A (en) 1-(4-hydroxy-3,5-di-tert.- butylbenzoyl) homopiperazine, various derivatives thereof, processes for the preparation of these and pharmaceutical compositions containing them
DE3778008D1 (de) Ketonderivate als arzneimittel zur behandlung oder vorbeugung des entzugssyndromes.
NO177312C (no) Fremgangsmåte for fremstilling av hirudinderivater med forsinket virkning
NO990547D0 (no) Farmas°ytiske produkter for behandling og forhindring av sykdommer forbundet med funksjonsfeil i vaskulµre endotelceller
IL117816A0 (en) N-subsituted azaheterocyclic compounds their preparation and pharmaceutical compositions containing them
KR920702225A (ko) 약학 조성물
DK1231908T3 (da) Farmaceutisk præparat, der omfatter en NO-donorforbindelse samt anvendelse heraf
KR920019356A (ko) 약제학적 조성물 및 그 제조방법
FI891210A (fi) Tiosulfinsyraderivat, deras anvaendning vid inflammationssjukdomar samt laekemedel innehaollande dessa aemnen.
DK65691D0 (da) 2-aminocarboxylsyre-derivater, deres fremstilling og anvendelse som laegemidler